Methyl 1-(3-BroMophenyl)-4-oxocyclohexanecarboxylate
|
- $439 - $790.5
- Product name: Methyl 1-(3-BroMophenyl)-4-oxocyclohexanecarboxylate
- CAS: 1385694-79-0
- MF: C14H15BrO3
- MW: 311.17
- EINECS:
- MDL Number:MFCD22423146
- Synonyms:Methyl 1-(3-BroMophenyl)-4-oxocyclohexanecarboxylate;Cyclohexanecarboxylic acid, 1-(3-bromophenyl)-4-oxo-, methyl ester;methyl 1-(3-bromophenyl)-4-oxocyclohexane-1-carboxylate
4 prices
Selected condition：
Brand
- AK Scientific
- Alichem
- Chemenu
- Crysdot
Package
- 5g
- ManufacturerAK Scientific
- Product number6866AJ
- Product descriptionMethyl1-(3-bromophenyl)-4-oxocyclohexanecarboxylate
- Packaging5g
- Price$728
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1385694790
- Product descriptionMethyl1-(3-bromophenyl)-4-oxocyclohexanecarboxylate
- Packaging5g
- Price$790.5
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM320819
- Product descriptionmethyl1-(3-bromophenyl)-4-oxocyclohexane-1-carboxylate 95%
- Packaging5g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12146600
- Product descriptionMETHYL1-(3-BROMOPHENYL)-4-OXOCYCLOHEXANECARBOXYLATE 95+%
- Packaging5g
- Price$465
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 6866AJ | Methyl1-(3-bromophenyl)-4-oxocyclohexanecarboxylate | 5g | $728 | 2021-12-16 | Buy |
| Alichem | 1385694790 | Methyl1-(3-bromophenyl)-4-oxocyclohexanecarboxylate | 5g | $790.5 | 2021-12-16 | Buy |
| Chemenu | CM320819 | methyl1-(3-bromophenyl)-4-oxocyclohexane-1-carboxylate 95% | 5g | $439 | 2021-12-16 | Buy |
| Crysdot | CD12146600 | METHYL1-(3-BROMOPHENYL)-4-OXOCYCLOHEXANECARBOXYLATE 95+% | 5g | $465 | 2021-12-16 | Buy |
Properties
Boiling point :397.7±42.0 °C(Predicted)
Density :1.418±0.06 g/cm3(Predicted)
Density :1.418±0.06 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|